Mark Mitton-Fry

Mark Mitton-Fry

Mark Mitton-Fry, PhD

Assistant Professor
Unit / Department / Division
Medicinal Chemistry and Pharmacognosy
Parks Hall
Email Address
Phone Number

Professional Interests

Professional Interests

Dr. Mitton-Fry’s research team is dedicated to inventing cures for multidrug-resistant bacterial infections. The lab uses the tools of synthetic medicinal chemistry to design and prepare innovative new molecules, and we collaborate broadly to evaluate their biological, pharmaceutical, and toxicological properties. Dr. Mitton-Fry also enjoys teaching students at all levels about antibacterial therapies.


  • 2002, PhD, University of Colorado Boulder
  • 1996, BA, Carleton College

Journal Articles

  • Li, L.; Okumu, A. A.; Nolan, S.; English, A.; Vibhute, S.; Lu, Y.; Hervert-Thomas, K.; Seffernick, J. T.; Azap, L.; Cole, S. L.; Shinabarger, D.; Koeth, L. M.; Lindert, S.; Yalowich, J. C.; Wozniak, D. J.; Mitton-Fry, M. J. 1,3-Dioxane-Linked Bacterial Topoisomerase Inhibitors with Enhanced Antibacterial Activity and Reduced hERG Inhibition. ACS Infect Dis, 2019, 5, 1115-1128.
  • Li, L.; Okumu, A.; Dellos-Nolan, S.; Li, Z.; Karmahapatra, S.; English, A.; Yalowich, J. C.; Wozniak, D. J.; Mitton-Fry, M. J. Synthesis and Anti-staphylococcal activity of Novel Bacterial Topoisomerase Inhibitors with a 5-amino-1,3-dioxane Linker Moiety. Bioorg. Med. Chem. Lett. 2018, 28, 2477-2480.